AOL Web Search

  1. About 41 search results

    75.57+1.11 (+1.49%)

    at Fri, Aug 12, 2022, 4:00PM EDT - U.S. markets closed

    After Hours 75.68 +0.11 (+0.15%)

    Delayed Quote

    • Open 74.58
    • High 75.72
    • Low 74.57
    • Prev. Close 74.46
    • 52 Wk. High 80.59
    • 52 Wk. Low 53.22
    • P/E 25.11
    • Mkt. Cap 161.36B
  1. Web results:
  2. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.

  3. Bristol Myers Squibb | LinkedIn

    Bristol Myers Squibb Pharmaceutical Manufacturing Lawrence Township, NJ 1,044,447 followers We discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

  4. BMY | Bristol Myers Squibb Co. Stock Overview (U.S.: NYSE ...

    Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.

  5. Bristol Myers Squibb Teams Up with Jack and Jill of America Inc. to Expand Tomorrow’s Innovators Program to Increase Black Representation in the Healthcare Industry 07/20/2022 Bristol Myers Squibb Launches Disability Diversity in Clinical Trials (DDiCT) Initiative to Improve Healthcare Outcomes for People with Disabilities

  6. Bristol Myers Squibb is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, protected veteran status, pregnancy, citizenship, marital status, gender expression, genetic information ...

  7. Bristol-Myers Squibb — Wikipédia

    Bristol Myers Squibb (BMS) En 1994, Bristol-Myers Squibb acquiert l'entreprise française UPSA, 4 ans après avoir pris 45 % de son capital En 2001, Bristol-Myers Squibb scinde ses activités dans le matériel médical dans une nouvelle entreprise, Zimmer Holdings. En 2009, Bristol-Myers Squibb se sépare de sa filiale de nutrition infantile ...

  8. Bristol-Myers Squibb Completes Acquisition of Celgene ...

    Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has completed its acquisition of Celgene Corporation (NASDAQ:CELG) following the receipt of regulatory approval from all government authorities required by the merger agreement and, as announced on April 12, 2019, approval by Bristol-Myers Squibb and Celgene stockholders. Upon completion of the acquisition, pursuant to the terms ...

  9. Learn more about Bristol Myers Squibb and our mission to discover, develop and deliver innovative medicines to patients with serious diseases.

  10. Products and Medicines - Bristol Myers Squibb

    Bristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.

  11. BMY - Bristol-Myers Squibb Co Stock quote -

    Find real-time BMY - Bristol-Myers Squibb Co stock quotes, company profile, news and forecasts from CNN Business.